BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10577908)

  • 1. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
    Rizzo WB; Carney G; Lin Z
    Am J Hum Genet; 1999 Dec; 65(6):1547-60. PubMed ID: 10577908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-based mutation screening in German families with Sjögren-Larsson syndrome.
    Kraus C; Braun-Quentin C; Ballhausen WG; Pfeiffer RA
    Eur J Hum Genet; 2000 Apr; 8(4):299-306. PubMed ID: 10854114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
    Rizzo WB; Carney G
    Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common deletion mutation in European patients with Sjögren-Larsson syndrome.
    Rizzo WB; Carney G; De Laurenzi V
    Biochem Mol Med; 1997 Dec; 62(2):178-81. PubMed ID: 9441870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
    Rizzo WB; Lin Z; Carney G
    Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome.
    Sillén A; Anton-Lamprecht I; Braun-Quentin C; Kraus CS; Sayli BS; Ayuso C; Jagell S; Küster W; Wadelius C
    Hum Mutat; 1998; 12(6):377-84. PubMed ID: 9829906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
    Carney G; Wei S; Rizzo WB
    Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren-Larsson syndrome is caused by a common mutation in northern European and Swedish patients.
    De Laurenzi V; Rogers GR; Tarcsa E; Carney G; Marekov L; Bale SJ; Compton JG; Markova N; Steinert PM; Rizzo WB
    J Invest Dermatol; 1997 Jul; 109(1):79-83. PubMed ID: 9204959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in the FALDH gene identified in Sjögren-Larsson syndrome patients originating from the northern part of Sweden.
    Sillén A; Jagell S; Wadelius C
    Hum Genet; 1997 Aug; 100(2):201-3. PubMed ID: 9254849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.
    Didona B; Codispoti A; Bertini E; Rizzo WB; Carney G; Zambruno G; Dionisi-Vici C; Paradisi M; Pedicelli C; Melino G; Terrinoni A
    J Hum Genet; 2007; 52(10):865-870. PubMed ID: 17902024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
    Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H
    Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gatekeeper helix determines the substrate specificity of Sjögren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase.
    Keller MA; Zander U; Fuchs JE; Kreutz C; Watschinger K; Mueller T; Golderer G; Liedl KR; Ralser M; Kräutler B; Werner ER; Marquez JA
    Nat Commun; 2014 Jul; 5():4439. PubMed ID: 25047030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large contiguous gene deletions in Sjögren-Larsson syndrome.
    Engelstad H; Carney G; S'aulis D; Rise J; Sanger WG; Rudd MK; Richard G; Carr CW; Abdul-Rahman OA; Rizzo WB
    Mol Genet Metab; 2011 Nov; 104(3):356-61. PubMed ID: 21684788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene.
    Lin Z; Carney G; Rizzo WB
    Mol Genet Metab; 2000 Nov; 71(3):496-505. PubMed ID: 11073717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete Sjögren-Larsson syndrome in two Japanese siblings.
    Kawakami T; Saito R; Fujikawa Y; Kazama H; Shinomiya N; Yamaguchi K; Yamaguchi Y; Aoki T; Kobayashi T
    Dermatology; 1999; 198(1):93-6. PubMed ID: 10026413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype and phenotype variability in Sjögren-Larsson syndrome.
    Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
    Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.